Patients being treated with dupilumab for atopic dermatitis (AD) may experience less severe Covid-19 symptoms, according to a new study.
top of page
it's where dermatology lives
bottom of page
Patients being treated with dupilumab for atopic dermatitis (AD) may experience less severe Covid-19 symptoms, according to a new study.
Comments